Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

Clinical trial NCT01706185 · COMPLETED

Trial details

NCT number: NCT01706185
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Neoplasms, Urinary Bladder

Start date: 2008-01-15
Primary completion: 2008-01-15
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.